Related Experiment Video
Updated: Jun 27, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function
C M Bastardo1, S Sonnappa, S Stanojevic
1Portex Anaesthesia, Intensive Therapy and Respiratory Medicine Unit, UCL, Institute of Child Health, London, UK.
Insights
Children with non-cystic fibrosis bronchiectasis experience adequate growth, but lung function stabilizes rather than normalizes. Early detection and treatment are crucial for managing this childhood respiratory condition.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Child Health
Background:
- Non-cystic fibrosis (non-CF) bronchiectasis is a chronic respiratory condition often originating in childhood.
- Its long-term effects on growth and lung function throughout childhood are not well understood.
- Understanding disease progression is key to improving adult outcomes.
Purpose of the Study:
- To longitudinally assess growth and lung function in children diagnosed with non-CF bronchiectasis.
- To identify patterns of disease progression during childhood.
- To inform early detection and treatment strategies.
Main Methods:
- Retrospective review of medical records for patients with non-CF bronchiectasis.
- Inclusion criteria: at least three years of available lung function data.
- Analysis of anthropometric measurements and spirometry over two and four-year periods using Generalised Estimating Equations.
Main Results:
- Fifty-nine children (31 boys) were analyzed, with a median age of 8.2 years at baseline.
- Over two years, significant improvements were observed in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) z-scores annually.
- Over four years, height-for-age z-scores improved, but other anthropometric measures and spirometry showed no significant change.
Conclusions:
- Children with non-CF bronchiectasis demonstrate adequate physical growth during the study period.
- While lung function stabilizes with treatment, it does not reach normal levels.
- Emphasizes the critical importance of early diagnosis and prompt initiation of effective therapies for non-CF bronchiectasis.
Background:
Non-cystic fibrosis (non-CF) bronchiectasis often starts in childhood with a significant impact on adult morbidity. Little is known about disease progression through childhood and the effect on growth and spirometry. This study reviews longitudinal lung function and growth in children with non-CF bronchiectasis.
Methods:
The case notes of patients with non-CF bronchiectasis were reviewed retrospectively. Patients were included if at least three calendar years of lung function data were available. Anthropometric measurements and annual spirometry were analysed over both two and four consecutive years. Changes over time were assessed using Generalised Estimating Equations.
Results:
Fifty-nine patients (31 boys) were identified. At baseline the median age was 8.2 years (range 4.8-15.8), the mean (SD) for height, weight and body mass index (BMI) for age z-scores were -0.68 (1.31), -0.19 (1.34) and 0.19 (1.38), respectively. At baseline, the mean (SD) z-score for forced expiratory volume in 1 s (FEV(1)) was -2.61 (1.82). Over 2 years (n = 59), mean FEV(1) and forced vital capacity (FVC) improved by 0.17 (95% CI 0.01 to 0.34, p = 0.039) and 0.21 (95% CI 0.04 to 0.39, p = 0.016) z-scores per annum, respectively. Over 4 years there was improvement in height-for-age z-scores (slope 0.05, 95% CI 0.01 to 0.095, p = 0.01) but no improvement in other anthropometric variables. There was no change in spirometry (FEV(1) slope 0.00, 95% CI -0.09 to 0.09, p = 0.999 and FVC slope 0.09, 95% CI -0.09 to 0.1, p = 0.859).
Conclusions:
Children with non-CF bronchiectasis show adequate growth over time. Lung function stabilises but does not normalise with treatment, underscoring the need for early detection and institution of appropriate therapy.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction

